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b Istituto Stomatologico Italiano, Dipartimento di Patologia Orale, Via Pace, 21, 20122 Milano, ItalyReceived 3 October 2005; accepted 5 October 2005Summary Primary (extranodal) non-Hodgkin’s lymphoma (NHL) of the oral cavity is relatively
rare. We report a case of NHL involving the left anterior mandibular gingiva of a 56-year-old
man. He was initially treated with antibiotics and root canal therapy of the lower lateral inci-
sor as there was a history of trauma to this area. The adjacent lateral incisor tested non-vital.
However, after 2 weeks of antibiotic therapy the swelling increased in size and an incisional
biopsy was performed. A diagnosis of non-Hodgkin’s lymphoma, large-B cell type was ren-
dered. The patient was then referred to medical oncology for staging work-up and treatment.
A course of six cycles of CHOP chemotherapy (Cyclophosphamide, Hydroxydoxorubicin, Onco-
vin, Prednisone) and radiotherapy were scheduled. There was a complete response upon com-
pletion of the combined chemotherapy and radiotherapy. One year later, the patient
developed a 2 · 2-cm, painless, firm, fixed mass of the left anterior maxillary vestibule. No
additional findings were noted clinically. Magnetic resonance imaging (MRI) confirmed the clin-
ical findings and there was no suspicion of disease elsewhere. Pathologic examination revealed
non-Hodgkin’s lymphoma, B-cell type. This lesion was identical morphologically and immuno-
phenotypically to the initial mandibular lesion. Complete radiographic staging detected no
other sites of disease. The bone marrow was not involved. The lesion rapidly normalized after
six cycles of Fludara, Novantrone and Mabthera chemotherapy and one cycle of Cytarabine
(Ara-C). Partial remission was achieved, but the patient died of disseminated disease, 12
months after relapse. There was an associated HCV infection, which may have played a role
in the fatal outcome.c 2005 Elsevier Ltd. All rights reserved.
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Figure 1 Photograph showing initial presentation of the
lesion in the left anterior site of the mandible.
Figure 2 A computed tomographic scan of the patient’s
mandible shows loss of lamina dura and widening of periodontal
ligament.
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Non-Hodgkin’s lymphoma (NHL) arises primarily within the
lymph nodes, but approximately 24% affect extranodal loca-
tions.1,2 The most frequent extranodal sites include the gas-
trointestinal tract, skin, bones, and Waldeyer’s ring. The
reported incidence of oral NHL ranges from 0.1% to 5%.2–7
In the oral cavity, NHL may occur within soft tissue or bone,
affecting the paranasal sinuses, gingiva, floor of the mouth,
buccal sulcus, salivary gland, or cheek. The most commonly
affected sites are the Waldeyer’s ring and the palate.5,6
Few cases of gingival lymphomas have been reported:
Gould and Alpert8 reported a case that involved the maxil-
lary labial attached gingiva; Fukuda et al.9 reviewed 20
cases of malignant lymphoma of the oral cavity, 17 of which
originated in the soft tissues and three involved the jaw
bones; Park10 reported a case of NHL of the right anterior
maxillary gingiva and antrum; Yasumoto et al.11 reported
an MRI study of gingival lymphoma; Raut et al.12 reported
an unusual gingival presentation; Epstein et al.13 reviewed
361 cases and reported seven gingival presentations; van
der waal et al.14 reported 40 cases occurring in the oral cav-
ity, 24 in the soft tissues and 16 intraosseous lesions; and in
2005 Kobler et al.15 reported one gingival case.
Oral NHL lesions may develop in the soft tissues or cen-
trally within the jaws, with or without nodal or marrow
involvement. They appear as non-tender swellings com-
monly affecting the vestibule, gingiva or palatal mucosa;
clinically the lesion may mimic inflammatory processes.
The World Health Organization classification of lym-
phoma16 updates the Revised European American Classi-
fication of Lymphoid Neoplasms (REAL) classification.
Non-Hodgkin’s lymphomas are subclassified by the Working
Formulation17 into low, intermediate, and high-grade varie-
ties. High-grade lymphomas are generally chemosensitive;
central nervous system or bone marrow involvement ad-
versely affects prognosis. The most widely used system for
staging lymphomas is the Ann Arbor classification, initially
introduced for Hodgkin’s lymphoma18,19 and later adopted
to classify non-Hodgkin’s lymphomas. Stage I comprises
lymphomas localized and confined to one side of the dia-
phragm with a single lesion; Stage IE indicates a single
extralymphatic organ or site involved. Stage II implies the
presence of 2 or more sites of involvement on the same side
of the diaphragm; Stage IIE the localized involvement of an
extra-lymphatic organ or site. Stage III indicates involve-
ment of multiple lymph nodes on both sides of the dia-
phragm, including involvement of the spleen or localized
involvement of an extra-lymphatic site. Stage IV is diffuse
or disseminated involvement that may include one or more
extra-lymphatic organs other than the spleen (i.e., liver or
bone marrow). The prognosis generally worsens as the dis-
ease stage increases.
Case report
A 56-year-old man presented with a rapidly progressive
swelling of the left anterior mandibular buccal gingiva
(Fig. 1). The panoramic radiograph was unremarkable.
Clinical examination revealed a firm soft tissue swelling
that measured 1.5 · 1.0 cm. He was initially treated withantibiotics and root canal therapy of the lower lateral inci-
sor, as this tooth tested non-vital. However, after 14 days of
antibiotic therapy the lesion continued to increase in size,
and incisional biopsy was performed. No palpable cervical
nodes were present (Fig. 2). The lesion was composed of dif-
fuse predominantly large lymphocytes. The immunohisto-
chemical panel revealed these to be B-cells, which
showed a positive staining reaction for CD20 and Ki 67 (Figs.
3 and 4). Together, these findings led to a final diagnosis of
malignant lymphoma; diffuse, large B-cell type. A computed
tomographic scan of the patient’s mandible revealed loss of
lamina dura and widening of periodontal ligament (Fig. 2).
The patient was then referred to medical oncology for
staging workup and treatment. Six courses of combina-
tion chemotherapy with, CHOP (cyclophosphamide,
hydroxydoxorubicin, oncovin, prednisone) and radiotherapy
were scheduled. The sixth cycle of chemotherapy was
stopped because of raised transaminase levels. There was
complete remission (Fig. 5). The medical work-up identified
Figure 6 Photograph showing a recurrence in the left
anterior site of the maxilla.
Figure 3 Photomicrograph of immunohistochemical stain
shows sheets of large mononuclear lymphoid cells positive for
CD20 (original magnification ·20).
Figure 5 Photograph shows a follow-up status after 5 treat-
ments of systemic chemotherapy: good clinical response to
treatment.
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was normal; routine blood and urine chemistry was normal
except for elevated liver enzyme levels. Anti-hepatitis C
virus (HCV) antibodies were detected by recombinant
immunoblot assay. Chest radiograph, abdominal CT scan,
and nuclear bone scan were unremarkable. Bone marrow
aspiration biopsy was normal. Remission was achieved.
One year later he developed a swelling of the maxillary ves-
tibule and gingiva (Fig. 6). Computerized tomography (CT)
of the head and neck confirmed the anterior maxillary mass,
measuring approximately 2.0 · 2.0 cm in diameter. MRI
failed to reveal bone involvement (Fig. 7). The regional
lymph nodes were not involved clinically nor were there
any suspicious nodes on imaging of the neck. The maxillary
mass was excised. Histological examination revealed a tu-
mor identical to the prior mandibular gingival lesion (Figs.
8–10). In the postoperative period the patient was treatedFigure 4 Photomicrograph of diffuse large B-cells with clear cytoplasm, prominent nucleoli, non-cleaved nuclei and rare mitotic
figures. Immunohistochemical staining for CD3 showing negative staining around the tumor cells (original magnification ·40).
Figure 7 RMI shows soft tissue involvement of the left
anterior site of the maxilla.
Figure 8 Photomicrograph showing large cells with vesicular
nuclei, prominent nucleoli, basophilic cytoplasm, and mitotic
figures. (hematoxylin–eosin, original magnification ·40).
Figure 9 Photomicrograph for immunohistochemical staining
showing positive for CD20 (original magnification ·40).
Figure 10 Photomicrograph of immunohistochemical staining
showing negative for ALK1 (original magnification ·20).
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motherapy and one cycle of Cytarabine (Ara-C). The patient
died 12 months after relapse, despite an initial response.
There was an associated HCV infection, which may have
played a role in the fatal outcome.
Pathological finding
Microscopically (hematoxylin and eosin stain) the lesion
consisted of a diffuse proliferation of large atypical lym-
phoid cells with clear cytoplasm. Mitotic figures were infre-
quently identified. The cells were large, isolated or in small
groups, demonstrating a moderate amount of cytoplasm
with large, round-to-oval nuclei containing coarse chroma-
tin and variably sized nucleoli. Focally, prominent nuclear
irregularity and pleomorphism were evident. Some cells
were binucleate. Immunohistochemical reactions showed
these cells to belong to the B-lymphocyte line. The second
biopsy specimen confirmed the diagnosis of B cell-non-
Hodgkin’s lymphoma; diffuse, large cell type.
Immunohistochemistry
Immunohistochemistry was performed using standard tech-
niques.20 We used a panel of monoclonal antibodies for
the following markers: CD20 (selective marker that recog-
nizes a subpopulation of B-cells); CD10 (marker for follicular
center B-cells and granulocytes), CD3 (marker for T-cells
and NK cells), CD30 (marker for activated T- and B-cells),
ALK-1 (marker for anaplastic large cells) and Ki 67 (prolifer-
ation marker). Both biopsy specimens were positive for
CD20 and Ki 67 and negative for CD3, CD10, CD30, and
ALK-1. A diagnosis of non-Hodgkin’s lymphoma, diffuse,
large B-cell type was rendered.
Discussion
Lymphoma is the second commonest neoplasm of the head
and neck, following squamous cell carcinoma.13 Most occur
in the Waldeyer’s ring, (e.g., tonsils, pharynx, base of the
tongue). Occurrence in the oral cavity proper is rare.
Primary NHL of the mandibular gingiva with maxillary gingival recurrence 127Given an appropriate clinical setting, extranodal lym-
phoma must be considered in differential diagnosis. The
first important factor in the diagnosis of extranodal lym-
phoma involving the oral cavity is to determine whether
the lesion is a dental abscess, a periodontal infection, a pri-
mary lymphoma of the oral cavity or a manifestation of
more disseminated disease. In the head and neck region,
lymphoma should be considered when there is unexplained
dental pain, numbness, tooth mobility, swelling, ulceration,
a mass in an extraction socket, or any ill-defined lytic osse-
ous changes.
In our case, the gingiva was the first location and clini-
cally the lesion appeared as a nodular mass, erythematous
and inflamed, but without ulceration, associated with a
non-vital tooth. There was a history of trauma to this area
and the panoramic film showed no bone abnormalities.
The general dentist applied endodontic treatment to the
non-vital tooth. When the patient was seen for follow-up
2 weeks after his initial appointment the swelling had in-
creased. An incisional biopsy was performed and a diagnosis
of diffuse large B-cell lymphoma was rendered.
The current staging procedures for extranodal oral lym-
phoma include a panoramic radiograph, abdominal and
chest CT scan, bone scans, routine laboratory tests (hemo-
gram, urine analysis, complete blood cell counts, lactate
dehydrogenase and erythrocyte sedimentation rate), and
bone marrow aspiration biopsy.
A diagnosis of bone lymphoma cannot be established on
the basis of radiography alone. Approximately 80% of bone
lesions exhibit osteolytic erosive features, whereas the
remaining 20% show sclerotic or mixed radiographic appear-
ance.21–23 The medical evaluation of this patient revealed
chronic hepatitis C virus (HCV), his complete blood count
was normal; routine laboratory tests, chest radiograph,
and bone marrow biopsy were normal.
The diagnosis was established through histological exam-
ination of biopsy tissue, coupled with immunohistochemical
phenotyping. Immunohistochemistry plays an important role
in distinguishing cell types and differential diagnosis.24 We
used CD20, CD10, CD3, CD30, ALK-1 and Ki 67 and found
both biopsy specimens to be positive for CD20 and Ki 67
and negative for CD3, CD10, CD30, ALK-1. We consequently
diagnosed diffuse large-B cell lymphoma.
The concomitant HCV infection is of interest in this case.
Recent epidemiological studies have revealed an association
between HCV infection and the clonal proliferation of B-
cells.23–25 It has been suggested26–31 that chronic antigenic
stimulation (related to the Epstein–Barr virus, human
immunodeficiency virus, human leukemia-lymphoma virus
1, human herpes virus 8 or hepatitis viruses B, C and G) acts
on multiple B-cell clones, which may synchronously or meta-
chronously undergo neoplastic transformation. In particu-
lar, B-cell lymphoma has been reported to be frequently
associated with or related to HCV infection.
In our case, which was clinically cured for NHL, a subse-
quent manifestation of B-cell lymphoma in the soft tissue
vestibule of the maxilla, detected one year later and after
complete remission, was considered to be a recurrence. Sev-
eral studies have indicated that a second occurrence after a
short period of time (<2–3 years), presenting the same his-
tological properties as the primary lymphoma, should be
considered a recurrence of the primary tumor, whereasdifferent histopathology and longer time before recurrence
are more indicative of a second primary lymphoma.32,33
The morphological characteristics of the second biopsy
specimen were identical to those of the first specimen.
The patient was treated as for a recurrence with chemo-
therapy; he did well for five months, but died two years
after the initial diagnosis.
Prognosis is influenced by clinical stage and histologic
grade. Large cell lymphomas are considered aggressive
and have a poorer prognosis.34–36 It is reported that diffuse
large-cell types of NHL are considered high grade, with a 5-
year survival of about 30%, whereas the follicular, small
cleaved-cell type are considered low grade, with a 5-year
survival rate of 70%.37–41
The present case was high-grade diffuse large B-cell type
lymphoma, as indicated in the REAL classification, and the
clinical stage was IIE with soft tissue involvement; thus
prognosis was poor; and in fact the patient died within a
year. In brief, we report a case of primary non-Hodgkin’s
lymphoma of the anterior vestibule of the mandible, with
a recurrence at the left upper site in the maxillary vestibule
that, to our knowledge, has not been reported previously.
There was an associated HCV infection. The high potential
for recurrence of this type of tumor, in addition to the role
played by chemotherapeutic agents, and the role of chronic
antigenic stimulation (specifically the hepatitis C virus)
which has been linked to the development of some lym-
phoma subsets, can facilitate the development of a recur-
rence or of a second primary tumor. It appears that such
an association may produce a recurrence that is more
aggressive and, in this case, fatal.References
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